282 related articles for article (PubMed ID: 12678566)
1. Breast cancer management: quality-of-life and cost considerations.
Radice D; Redaelli A
Pharmacoeconomics; 2003; 21(6):383-96. PubMed ID: 12678566
[TBL] [Abstract][Full Text] [Related]
2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
4. [Direct and indirect diabetes costs in the world].
Logminiene Z; Norkus A; Valius L
Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and economic considerations in the management of prostate cancer.
Turini M; Redaelli A; Gramegna P; Radice D
Pharmacoeconomics; 2003; 21(8):527-41. PubMed ID: 12751912
[TBL] [Abstract][Full Text] [Related]
6. The Economic Burden of Breast Cancer in Korea from 2007-2010.
Kim YA; Oh IH; Yoon SJ; Kim HJ; Seo HY; Kim EJ; Lee YH; Jung JH
Cancer Res Treat; 2015 Oct; 47(4):583-90. PubMed ID: 25687860
[TBL] [Abstract][Full Text] [Related]
7. Cost of breast cancer in Sweden in 2002.
Lidgren M; Wilking N; Jönsson B
Eur J Health Econ; 2007 Mar; 8(1):5-15. PubMed ID: 17216424
[TBL] [Abstract][Full Text] [Related]
8. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
10. Screening, prevention and socioeconomic costs associated with the treatment of colorectal cancer.
Redaelli A; Cranor CW; Okano GJ; Reese PR
Pharmacoeconomics; 2003; 21(17):1213-38. PubMed ID: 14986736
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors.
de Koning HJ; van Ineveld BM; van Oortmarssen GJ; de Haes JC; Collette HJ; Hendriks JH; van der Maas PJ
Int J Cancer; 1991 Oct; 49(4):531-7. PubMed ID: 1917154
[TBL] [Abstract][Full Text] [Related]
12. A review of the health-related quality of life and economic impact of Parkinson's disease.
Dowding CH; Shenton CL; Salek SS
Drugs Aging; 2006; 23(9):693-721. PubMed ID: 17020395
[TBL] [Abstract][Full Text] [Related]
13. Economic burden from smoking-related diseases in Thailand.
Bundhamcharoen K; Aungkulanon S; Makka N; Shibuya K
Tob Control; 2016 Sep; 25(5):532-7. PubMed ID: 26427527
[TBL] [Abstract][Full Text] [Related]
14. The costs of treating breast cancer in the US: a synthesis of published evidence.
Campbell JD; Ramsey SD
Pharmacoeconomics; 2009; 27(3):199-209. PubMed ID: 19354340
[TBL] [Abstract][Full Text] [Related]
15. Assessing the economic burden of breast cancer in a US managed care population.
Barron JJ; Quimbo R; Nikam PT; Amonkar MM
Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
17. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care.
Taplin SH; Barlow W; Urban N; Mandelson MT; Timlin DJ; Ichikawa L; Nefcy P
J Natl Cancer Inst; 1995 Mar; 87(6):417-26. PubMed ID: 7861461
[TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness of trastuzumab in the treatment of early stages breast cancer patients, in Portugal].
Macedo A; Monteiro I; Andrade S; Cirrincione A; Ray J
Acta Med Port; 2010; 23(3):475-82. PubMed ID: 20654267
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a surveillance programme for women with a family history of breast cancer.
Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
[TBL] [Abstract][Full Text] [Related]
20. Costs of illness: United States, 1980.
Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
